drugset / Trial / NCT00301405
Open-Label Study of Thalidomide for Chronic Prostatitis/Chronic Pelvic Pain
Phase 2
Terminated
9 enrolled
Kenneth Peters, MD
Celgene Corporation · collabCorewell Health East · collab
NaSingle-groupOpen-labelTreatment
Summary
To determine the efficacy of thalidomide for treatment of the Chronic Pelvic Pain Syndrome (CPPS).
Timeline
- Start
- 2006-03
- Primary completion
- 2006-11
- Completion
- 2006-11
Outcome
Outcome not reported
Stopped (Enrollment): “Study closed. Difficult enrollment of patients with prostatitis.”
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Thalidomide | Other / unclassified | — | — |